Midatech Pharma plc (MTP) Q2 2021 Earnings Conference Call September 20, 2021 12:30 PM ET Company Participants Tim Metcalfe - MD, IFC Advisory Limited, IR Stephen Stamp - CEO & CFO Conference Call Participants Tim Metcalfe Well, it seems like most people are with us now. So welcome, my name is Tim Metcalfe. And with me today, I've got Stephen Stamp, who's CEO and CFO of Midatech Pharma. Unfortunately, Stephen is traveling on business at the moment, and where he is, the internet connection is not great. So u ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ OR o SHELL COMPANY PURSUANT T ...

Interims 2020 10 September 2020 The Midatech senior team | --- | --- | --- | --- | |-------|-------|-------|--------------------------------------------| | | | | LEFT TO RIGHT | | | | | Fiona Sharp | | | | | Group Controller | | | | | Sam Barker | | | | | Director Business Development | | | | | Stephen Stamp | | | | | CEO and CFO | | | | | Paul Seaman | | | | | VP Pharmaceutical & Technology Development | | | | | Steve Damment | | | | | EVP R&D | 2 Disclaimer The following presentation, including a hard cop ...

Midatech Pharma plc (MTP) Q2 2020 Earnings Conference Call September 10, 2020 9:00 AM ET Company Participants Tim Sparey - Chief Business Officer Stephen Stamp - CEO & CFO Conference Call Participants Tim Sparey Good afternoon from Cardiff and welcome to the Midatech Pharma 2020 Interim Results Presentation. With me is Stephen Stamp; CEO and CFO of the company who will run through the presentation. At the end of the presentation there will be a question-and-answer session. We've already received some questi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ OR o SHELL COMPANY PURSUANT T ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ OR ☐ SHELL COMPANY PURSUANT T ...